Although we were not able to carry out functional studies, we suggest this PLCG2 variant is associated with the phenotype of the patient, and diagnosis of APLAID could be confirmed due to the combination of characteristic phenotype and genotype results. The gene discussed is PLCG2; the disease is autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation.